Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

NCT02986139 ·Status: COMPLETED ·Phase: PHASE3

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

NCT02373813 ·Status: COMPLETED ·Phase: PHASE3

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept

NCT00034060 ·Status: COMPLETED ·Phase: PHASE2

Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes

NCT00094341 ·Status: COMPLETED ·Phase: PHASE4

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

NCT00110903 ·Status: COMPLETED ·Phase: PHASE3

Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept

NCT01388608 ·Status: COMPLETED

Remission Induction in Very Early Rheumatoid Arthritis

NCT00523692 ·Status: UNKNOWN ·Phase: PHASE4

Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)

NCT01313208 ·Status: COMPLETED ·Phase: PHASE4

Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

NCT04428424 ·Status: COMPLETED

Prospective Evaluation of the Radiographic Efficacy of Enbrel

NCT01623752 ·Status: COMPLETED

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

NCT01578850 ·Status: COMPLETED ·Phase: PHASE4

Etanercept SFP in RA Patients

NCT00413452 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis

NCT00195494 ·Status: COMPLETED ·Phase: PHASE4

Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan

NCT00888576 ·Status: COMPLETED

A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

NCT00484237 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis

NCT00443950 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

NCT00115219 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

NCT00393471 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

NCT01927757 ·Status: TERMINATED ·Phase: PHASE4

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

NCT00522184 ·Status: COMPLETED ·Phase: PHASE3

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

NCT01646385 ·Status: COMPLETED

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

NCT00713544 ·Status: COMPLETED ·Phase: PHASE2

Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice

NCT02202837 ·Status: COMPLETED